BiomX Faces NYSE Delisting Over Equity Deficiency
Company Announcements

BiomX Faces NYSE Delisting Over Equity Deficiency

BiomX (PHGE) has issued an announcement.

BiomX, Inc. has been notified by NYSE American that it’s not meeting the required listing standards due to a deficiency in stockholders’ equity, having reported losses over recent fiscal years. The company must submit a compliance plan by June 22, 2024, to regain compliance by November 23, 2025. BiomX recently raised $50 million, which wasn’t counted towards equity, but upcoming stockholder approval could convert preferred stock to common stock, potentially resolving the equity issue. Despite the notice, BiomX shares continue to trade, with a “.BC” indicator signaling their non-compliance status. The company’s future ability to comply with listing standards remains uncertain.

For a thorough assessment of PHGE stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiomX to present data from Phase 1b/2a study of BX004
GlobeNewswireBiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference
GlobeNewswireBiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App